Increased mucosal MPO activity can be used as a biomarker of oxidative stress and has been described in human patients with IBD (both Crohn’s disease [CD] and ulcerative colitis [UC]) [31–34] and also in animal models of human IBD [35–37]. The gene discussed is MPO; the disease is inflammatory bowel disease.